Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survivin as Predictive Biomarker for Development of Rheumatoid Arthritis

NCT03444623 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT03444623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03444623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survivin as Predictive Biomarker for Development of Rheumatoid Arthritis
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2013
Completion date
December 31, 2023
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthralgia, joint pain, rheumatoid arthritis